133 related articles for article (PubMed ID: 28815694)
1. Pemetrexed-induced lower limb pseudocellulitis.
Liau MM; Santosa A; Huang J; Tan LC
Clin Exp Dermatol; 2017 Dec; 42(8):914-916. PubMed ID: 28815694
[No Abstract] [Full Text] [Related]
2. Pemetrexed-Induced Pseudocellulitis Reaction With Eosinophilic Infiltrate on Skin Biopsy.
Tracey EH; Modi B; Micheletti RG
Am J Dermatopathol; 2017 Jan; 39(1):e1-e2. PubMed ID: 27415636
[TBL] [Abstract][Full Text] [Related]
3. PEMETREXED-INDUCED PSEUDOCELLULITIS - A RARE CUTANEOUS ADVERSE REACTION TO MULTI-TARGETED ANTIFOLATE THERAPY.
Wollina U; Hansel G; Zschuppe E; Tchernev G
Georgian Med News; 2017 Jun; (267):81-84. PubMed ID: 28745612
[TBL] [Abstract][Full Text] [Related]
4. Pemetrexed-induced pseudocellulitis.
Lo Y; Wu WH
Kaohsiung J Med Sci; 2020 Nov; 36(11):953-954. PubMed ID: 32643863
[No Abstract] [Full Text] [Related]
5. Pemetrexed-induced cellulitis: a rare toxicity in non-small cell lung cancer treatment.
Katsenos S; Psara A; Panagou C
J Oncol Pharm Pract; 2013 Mar; 19(1):93-4. PubMed ID: 22357637
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in non-small cell lung cancer patients who are recommended to receive single-agent chemotherapy (docetaxel or pemetrexed) as a second- or third-line chemotherapy: in the era of oncogenic drivers and molecular-targeted agents.
Shukuya T; Ko R; Mori K; Kato M; Yagishita S; Kanemaru R; Honma Y; Shibayama R; Koyama R; Shimada N; Takahashi K
Cancer Chemother Pharmacol; 2015 Oct; 76(4):771-6. PubMed ID: 26259641
[TBL] [Abstract][Full Text] [Related]
7. Neutrophilic dermatosis of the dorsal hands: an often under recognised and mistreated entity.
Leecy T; Anderson A; Von Nida J; Harvey N; Wood B
Pathology; 2013 Feb; 45(2):198-200. PubMed ID: 23277177
[No Abstract] [Full Text] [Related]
8. Pemetrexed-induced eyelid edema in lung cancer.
Martins-Filho PR; Kameo SY; Mascarenhas-Oliveira AC; Vieira NF; Azevedo E
J Craniofac Surg; 2013 Jul; 24(4):e401-3. PubMed ID: 23851735
[TBL] [Abstract][Full Text] [Related]
9. Sorbic acid-induced erythema and edema.
Soschin D; Leyden JJ
J Am Acad Dermatol; 1986 Feb; 14(2 Pt 1):234-41. PubMed ID: 3950121
[TBL] [Abstract][Full Text] [Related]
10. Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients.
Buti S; Bordi P; Tiseo M; Bria E; Sperduti I; Di Maio M; Panni S; Novello S; Rapetti SG; Pilotto S; Genestreti G; Rossi A; Pezzuolo D; Camisa R; Tortora G; Ardizzoni A
Lung Cancer; 2015 Jun; 88(3):319-24. PubMed ID: 25870156
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer.
Lal R; Hillerdal GN; Shah RN; Crosse B; Thompson J; Nicolson M; Vikström A; Potter VA; Visseren-Grul C; Lorenzo M; D'yachkova Y; Bourayou N; Summers YJ
Lung Cancer; 2015 Aug; 89(2):154-60. PubMed ID: 26101013
[TBL] [Abstract][Full Text] [Related]
12. Inflamed Actinic Keratoses After Pemetrexed.
Cameron MC; Suárez AL; Kris MG; Myskowski PL
Skinmed; 2016; 14(6):473-474. PubMed ID: 28031141
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine-related "pseudocellulitis": report of 2 cases and review of the literature.
Tan DH; Bunce PE; Liles WC; Gold WL
Clin Infect Dis; 2007 Sep; 45(5):e72-6. PubMed ID: 17682983
[TBL] [Abstract][Full Text] [Related]
14. Epiphora following chemotherapy with pemetrexed in patients with advanced non-small cell lung cancer.
Jung YD; Lee SB; Jung YW; Song JS; Woo IS
Korean J Intern Med; 2017 Sep; 32(5):923-925. PubMed ID: 28298078
[No Abstract] [Full Text] [Related]
15. Assessment of interfering factors and clinical risk associated with discontinuation of pemetrexed maintenance therapy in advanced non-squamous non-small cell lung cancer.
Shen L; Niu X; Jian H; Xu Y; Yu Y; Lu S
Lung Cancer; 2017 Sep; 111():43-50. PubMed ID: 28838396
[TBL] [Abstract][Full Text] [Related]
16. Gigantic erythematous plaques with violaceous oedematous borders: a quiz. Wells' syndrome.
Mechow N; Cosgarea I; Ogwang E; Franke I; Gollnick HP; Quist SR
Acta Derm Venereol; 2013 Nov; 93(6):763, 764. PubMed ID: 23572063
[No Abstract] [Full Text] [Related]
17. Phase II study of oral vitamin B12 supplementation as an alternative to intramuscular injection for patients with non-small cell lung cancer undergoing pemetrexed therapy.
Takagi Y; Hosomi Y; Nagamata M; Watanabe K; Takahashi S; Nakahara Y; Yomota M; Sunami K; Okuma Y; Shimokawa T; Okamura T
Cancer Chemother Pharmacol; 2016 Mar; 77(3):559-64. PubMed ID: 26821156
[TBL] [Abstract][Full Text] [Related]
18. [Pemetrexed-induced eyelid edema].
Badaoui A; Mahé E
Ann Dermatol Venereol; 2018 Dec; 145(12):769-772. PubMed ID: 30297200
[TBL] [Abstract][Full Text] [Related]
19. Generalized eczema craquelé (asteatotic dermatitis) associated with pemetrexed treatment.
Chu CH; Chou CY; Lin FL
J Eur Acad Dermatol Venereol; 2016 Oct; 30(10):e81-e83. PubMed ID: 26416293
[No Abstract] [Full Text] [Related]
20. Eyelid and feet edema induced by pemetrexed.
Kastalli S; Charfi O; Sahnoun R; Lakhoua G
Indian J Pharmacol; 2016; 48(6):741-742. PubMed ID: 28066120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
